LGND News

Stocks

Headlines

Ligand Pharmaceuticals Shares Drop Below 200-Day Average

Stocks in focus: Ligand Pharmaceuticals fell below its 200-day moving average. The shares are down by 3.1% today, indicating a potential negative trend. Investors may need to monitor this situation closely.

Date: 
AI Rating:   5

Stock Performance Insight: The current report highlights that Ligand Pharmaceuticals Inc (LGND) has dropped below its 200-day moving average, which is a significant indicator of stock performance. The share price has seen a decline of about 3.1%, which could raise concerns among investors regarding its stability.

Additionally, Ligand’s shares have a 52-week range with a low of $67.72 and a high of $129.90, currently marking a last trade price of $105.91. This suggests that while the stock has potential, it has recently faced downward pressure.